TALPHERA, INC. Increase (Decrease) in Contract with Customer, Liability
TALPHERA, INC. (TLPH) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2025-03-31
- TALPHERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2024-12-31 was $0.00.
- TALPHERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2024-09-30 was $0.00.
- TALPHERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2024-06-30 was $0.00.
- TALPHERA, INC. increase (decrease) in contract with customer, liability for the quarter ending 2024-03-31 was $0.00.
- TALPHERA, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was $0.00.
- TALPHERA, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was -$29.00K.
- TALPHERA, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$86.00K.
- TALPHERA, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$3.19M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | -$29.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | -$29.00K 10-Q · filed 2024-11-13 | -$72.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$29.00K 10-Q · filed 2024-08-14 | -$72.00K derived: sum of 3 quarters · filed 2024-08-14 | -$86.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$29.00K 10-Q · filed 2024-05-14 | -$72.00K derived: sum of 2 quarters · filed 2024-05-14 | -$86.00K derived: sum of 3 quarters · filed 2024-05-14 | -$115.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$57.00K derived: sum of 2 quarters · filed 2024-03-06 | -$86.00K derived: sum of 3 quarters · filed 2024-03-06 | -$86.00K 10-K · filed 2024-03-06 | |
| 2022-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$43.00K derived: sum of 2 quarters · filed 2023-11-14 | -$43.00K 10-Q · filed 2023-11-14 | -$43.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$29.00K 10-Q · filed 2023-08-10 | -$29.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.21M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-08-01 | $1.24M derived: sum of 3 quarters · filed 2023-08-01 | $1.24M derived: sum of 4 quarters · filed 2023-08-01 | |
| 2021-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | $1.24M derived: sum of 2 quarters · filed 2023-08-01 | $1.24M derived: sum of 3 quarters · filed 2023-08-01 | $1.19M 8-K · filed 2023-08-01 | |
| 2021-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.24M derived: sum of 2 quarters · filed 2022-11-14 | $1.19M 10-Q · filed 2022-11-14 | $1.04M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$49.00K 10-Q · filed 2022-08-11 | -$196.00K derived: sum of 3 quarters · filed 2022-08-11 | -$343.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$49.00K 10-Q · filed 2022-05-16 | -$196.00K derived: sum of 2 quarters · filed 2022-05-16 | -$343.00K derived: sum of 3 quarters · filed 2022-05-16 | -$3.17M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$294.00K derived: sum of 2 quarters · filed 2022-03-10 | -$3.12M derived: sum of 3 quarters · filed 2022-03-10 | -$3.19M 10-K · filed 2022-03-10 | |
| 2020-09-30 | -$147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$2.97M derived: sum of 2 quarters · filed 2021-11-15 | -$3.05M 10-Q · filed 2021-11-15 | -$3.03M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$2.90M 10-Q · filed 2021-08-16 | -$2.88M derived: sum of 3 quarters · filed 2021-08-16 | -$2.97M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$79.00K 10-Q · filed 2021-05-17 | -$62.00K derived: sum of 2 quarters · filed 2021-05-17 | -$149.00K derived: sum of 3 quarters · filed 2021-05-17 | -$341.00K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$70.00K derived: sum of 2 quarters · filed 2021-03-15 | -$262.00K derived: sum of 3 quarters · filed 2021-03-15 | -$219.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$279.00K derived: sum of 2 quarters · filed 2020-11-05 | -$236.00K 10-Q · filed 2020-11-05 | -$213.00K derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-06-30 | -$192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$149.00K 10-Q · filed 2020-08-10 | -$126.00K derived: sum of 3 quarters · filed 2021-03-15 | -$216.00K derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-03-31 | $43.00K 10-Q · filed 2020-05-11 | $66.00K derived: sum of 2 quarters · filed 2021-03-15 | -$24.00K derived: sum of 3 quarters · filed 2021-03-15 | -$115.00K derived: sum of 4 quarters · filed 2021-03-15 | |
| 2018-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$67.00K derived: sum of 2 quarters · filed 2021-03-15 | -$158.00K derived: sum of 3 quarters · filed 2021-03-15 | -$249.00K 10-K · filed 2021-03-15 | -$362.00K 10-K · filed 2019-03-07 |
| 2018-09-30 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$181.00K derived: sum of 2 quarters · filed 2019-11-07 | -$272.00K 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$182.00K 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | -$91.00K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$361.00K 10-K · filed 2020-03-16 | ||||
| 2016-12-31 | $989.00K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |